Monopar Therapeutics (MNPR) Debt Ratio (2020)

Name: Monopar Therapeutics (MNPR) Debt Ratio (2020) | Business Quant
Creator: Business Quant

Monopar Therapeutics has reported Debt Ratio over the past 1 years, most recently at 0.01 for Q3 2020.

Debt Ratio reached 0.01 in Q3 2020 per MNPR's latest filing, down from 0.01 in the prior quarter.
Across five years, Debt Ratio topped out at 0.01 in Q2 2020 and bottomed at 0.01 in Q3 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Quantum Biopharma	1,384,976.65 Bn	1,384,976.64 Bn	-	-
2	Alterity Therapeutics	777,208.84 Bn	777,208.81 Bn	-	-
3	Legend Biotech	2,801.00 Bn	2,800.10 Bn	242.10 Mn	0.18
4	Nanobiotix	2,226.01 Bn	2,225.95 Bn	-	1.41
5	Akari Therapeutics	605.66 Bn	605.66 Bn	-	-
6	Vertex Pharmaceuticals	110.17 Bn	102.92 Bn	2.59 Bn	-
7	Regeneron Pharmaceuticals	66.86 Bn	58.11 Bn	3.31 Bn	0.05
8	Evaxion A	65.12 Bn	65.10 Bn	-	-
9	Alnylam Pharmaceuticals	39.94 Bn	36.94 Bn	959.66 Mn	-
10	Monopar Therapeutics	466.82 Mn	466.82 Mn	-	-

Download Data 🔒

Date	Value
Sep 30, 2020	0.01
Jun 30, 2020	0.01